Exploring the prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma

키워드

참고문헌 (20)

1. Llovet JM, "Hepatocellular carcinoma", Nat Rev Dis Primers, 7, pp.6~ (2021)
2. Sankar K, "Recent advances in the management of hepatocellular carcinoma", Clin Mol Hepatol, 30, pp.1~15 (2024)
3. Tran NH, "Using cell-free DNA for HCC surveillance and prognosis", JHEP Rep, 3, pp.100304~ (2021)
4. Watanabe T, "Circulating cell-free DNA as a biomarker for prognosis and response to systemic therapy in patients with unresectable hepatocellular carcinoma", Oncology, 101, pp.714~722 (2023)
5. Alunni-Fabbroni M, "Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma : a translational exploratory study from the SORAMIC trial", J Transl Med, 17, pp.328~ (2019)
6. Sogbe M, "Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment", Clin Mol Hepatol, 30, pp.177~190 (2024)
7. Huang A, "Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma", J Hepatol, 67, pp.293~301 (2017)
8. Cai ZX, "Circulating tumor DNA profiling reveals clonal evolution and real-time disease progression in advanced hepatocellular carcinoma", Int J Cancer, 141, pp.977~985 (2017)
9. Huang A, "Detecting circulating tumor DNA in hepatocellular carcinoma patients using droplet digital PCR is feasible and reflects intratumoral heterogeneity", J Cancer, 7, pp.1907~1914 (2016)
10. Kim SS, "MLH1single-nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma", Sci Rep, 10, pp.17862~ (2020)
11. Cheishvili D, "A high-throughput test enables specific detection of hepatocellular carcinoma", Nat Commun, 14, pp.3306~ (2023)
12. Chat V, "Ultra low-coverage whole-genome sequencing as an alternative to genotyping arrays in genome-wide association studies", Front Genet, 12, pp.790445~ (2022)
13. Homburger JR, "Low coverage whole genome sequencing enables accurate assessment of common variants and calculation of genome-wide polygenic scores", Genome Med, 11, pp.74~ (2019)
14. Pasaniuc B, "Extremely low-coverage sequencing and imputation increases power for genome-wide association studies", Nat Genet, 44, pp.631~635 (2012)
15. Chen X, "Low-pass whole-genome sequencing of circulating cell-free DNA demonstrates dynamic changes in genomic copy number in a squamous lung cancer clinical cohort", Clin Cancer Res, 25, pp.2254~2263 (2019)
16. Nørgaard M, "Prognostic value of low-pass whole genome sequencing of circulating tumor DNA in metastatic castration-resistant prostate cancer", Clin Chem, 69, pp.386~398 (2023)
17. Shulman DS, "Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma : a report from the Children’s Oncology Group", Br J Cancer, 119, pp.615~621 (2018)
18. Abbas A, "Case report : Circulating tumor DNA fraction analysis using ultra-low-pass whole-genome sequencing correlates response to chemoradiation and recurrence in stage IV smallcell carcinoma of the cervix-A longitudinal study", Front Oncol, 11, pp.652683~ (2021)
19. Stover DG, "Association of cell-free DNA tumor fraction and somatic copy number alterations with survival in metastatic triple-negative breast cancer", J Clin Oncol, 36, pp.543~553 (2018)
20. Akhoundova D, "The grand challenge of moving cancer whole-genome sequencing into the clinic", Nat Med, 30, pp.39~40 (2024)

관련 논문AI추천